ARCHIVES

Isis 3521 Gets Fast-track Status For FDA Review.

This article is from The Cancer Letter archive.

Vol. 26 No. 44 | December 1, 2000

Download PDF Visit The Full Archive

Related Articles

ACS, NBCC Weigh Involvement In March, Ask What Happens Next

October 31, 1997

Trial: Decitabine Improves Survival in Myeloid Leukemia

July 29, 2011

Richard Pazdur’s Comments to ODAC

July 22, 2011

Letter to The Editor: IOM Panel Urges Greater Integration Of Research

February 12, 1999

FDA Approves Treatment For Late-Stage Cervical Cancer

June 30, 2006

Reagan’s Freeze Chills NCI Plan To Hire Outsiders

January 30, 1981